Risk of amyotrophic lateral sclerosis in patients with diabetes: A nationwide population-based cohort study

Journal of Epidemiology

Volumn 25, Issue 6, 2015, Pages 445-451

  Sun, Yu ^a   Lu, Chien Jung ^a   Chen, Rong Chi ^a   Hou, Wen Hsuan ^b,c   Li, Chung Yi ^d,e  

^a EN CHU KONG HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cohort study; Diabetes mellitus; Motor neuron disease; Relative risk

Indexed keywords

AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEX RATIO; TAIWAN;

AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SEX DISTRIBUTION; TAIWAN;

EID: 84930702045     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20140176     Document Type: Article

References (35)

1. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688-700.
2. Reyes ET, Perurena OH, Festoff BW, Jorgensen R, Moore WV. Insulin resistance in amyotrophic lateral sclerosis. J Neurol Sci. 1984;63:317-24.
3. Perurena OH, Festoff BW. Reduction in insulin receptors in amyotrophic lateral sclerosis correlates with reduced insulin sensitivity. Neurology. 1987;37:1375-9.
4. Pradat PF, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, Simon D, et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:166-71.
5. Jerusalem F, Pohl C, Karitzky J, Ries F. ALS. Neurology. 1996;47(6 Suppl 4):S218-20.
6. Rothstein JD. Excitotoxicity hypothesis. Neurology. 1996;47(4 Suppl 2):S19-25; discussion S26.
7. Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med. 2010;48:629-41.
8. Shi P, Gal J, Kwinter DM, Liu X, Zhu H. Mitochondrial dysfunction in amyotrophic lateral sclerosis. Biochim Biophys Acta. 2010;1802:45-51.
9. Abdul-Ghani MA, De Fronzo RA. Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus. Curr Diab Rep. 2008;8:173-8.
10. Park K, Gross M, Lee DH, Holvoet P, Himes JH, Shikany JM, et al. Oxidative stress and insulin resistance: the coronary artery risk development in young adults study. Diabetes Care. 2009;32: 1302-7.
11. Sivitz WI, Yorek MA. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal. 2010;12: 537-77.
12. Jayanarayanan S, Smijin S, Peeyush KT, Anju TR, Paulose CS. NMDA and AMPA receptor mediated excitotoxicity in cerebral cortex of streptozotocin induced diabetic rat: ameliorating effects of curcumin. Chem Biol Interact. 2013;201:39-48.
13. Armon C, Kurland LT, O'Brien PC, Mulder DW. Antecedent medical diseases in patients with amyotrophic lateral sclerosis. A population-based case-controlled study in Rochester, Minn, 1925 through 1987. Arch Neurol. 1991;48:283-6.
14. Lekoubou A, Matsha TE, Sobngwi E, Kengne AP. Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review. BMC Res Notes. 2014;7:171.
15. Lu JF, Hsiao WC. Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff (Millwood). 2003;22:77-88.
16. Chen HF, Ho CA, Li CY. Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients. Diabetes Care. 2006;29: 2409-14.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40: 373-83.
18. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47: 1245-51.
19. Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Neurology. 2008;70: 1423-30.
20. Tan HF, Tseng HF, Chang CK, Lin W, Hsiao SH. Accessibility assessment of the Health Care Improvement Program in rural Taiwan. J Rural Health. 2005;21:372-7.
21. Das K, Nag C, Ghosh M. Familial, environmental, and occupational risk factors in development of amyotrophic lateral sclerosis. N Am J Med Sci. 2012;4:350-5.
22. Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, Liu JS, et al. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;4:1-22.
23. Steinke J, Tyler HR. The association of amyotrophic lateral sclerosis (motor neuron disease) and carbohydrate intolerance, a clinical study. Metabolism. 1964;13:1376-81.
24. Harno K, Rissanen A, Palo J. Glucose tolerance in amyotrophic lateral sclerosis. Acta Neurol Scand. 1984;70:451-5.
25. Körner S, Kollewe K, Ilsemann J, Müller-Heine A, Dengler R, Krampfl K, et al. Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. Eur J Neurol. 2013;20:647-54.
26. Trudeau F, Gagnon S, Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol. 2004;490:177-86.
27. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes. 2003;52: 1-8.
28. Ince PG, Shaw PJ, Candy JM, Mantle D, Tandon L, Ehmann WD, et al. Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci Lett. 1994; 182:87-90.
29. Morley JE. The elderly Type 2 diabetic patient: special considerations. Diabet Med. 1998;15 Suppl 4:S41-6.
30. Vivian EM. Type 2 diabetes in children and adolescents-the next epidemic? Curr Med Res Opin. 2006;22:297-306.
31. Jordán J, Ceña V, Prehn JH. Mitochondrial control of neuron death and its role in neurodegenerative disorders. J Physiol Biochem. 2003;59:129-41.
32. National Health Insurance Administration Ministry of Health and Welfare. Regulations Governing Contracting and Management of National Health Insurance Medical Care Institutions. http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=295&WD_ID=295&webdata_id=2440. Accessed in March, 2014.
33. Sun Y, Chang YH, Chen HF, Su YH, Su HF, Li CY. Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications. Diabetes Care. 2012;35:1047-9.
34. Pisa FE, Verriello L, Deroma L, Drigo D, Bergonzi P, Gigli GL, et al. The accuracy of discharge diagnosis coding for Amyotrophic Lateral Sclerosis in a large teaching hospital. Eur J Epidemiol. 2009;24:635-40.
35. Sutedja NA, Veldink JH, Fischer K, Kromhout H, Wokke JH, Huisman MH, et al. Lifetime occupation, education, smoking, and risk of ALS. Neurology. 2007;69:1508-14.